{"cluster": 20, "subcluster": 25, "abstract_summ": "The ID NOW COVID-19 (IDNCOV) assay performed on the ID Now Instrument (Abbott Diagnostics, Scarborough, Inc. Scarborough, ME) is a rapid diagnostic test that can be performed in a point of care setting equivalent to CLIA waived testing.\u2026.We evaluated the rapid immunochromatographic test for SARS-CoV-2 antigen detection using 16 saliva specimens collected from 6 COVID-19 hospitalized patients, and detected N-antigen in 4 of 7 RT-PCR positive specimens.With the global outbreak of the novel coronavirus disease 2019, the demand for testing rapidly increased and quickly exceeded the testing capacities for many laboratories.Automation of workflows in molecular diagnostics is instrumental for coping with the large number of tests ordered by clinicians, as well as providing fast-tracked rapid testing for urgent cases.BACKGROUND: To track the European spread of SARS-CoV-2, decentralized testing became necessary and test capacity needed to be expanded outside reference laboratories rapidly.This study compared laboratory-developed tests (LDTs) used for the detection of SARS-CoV-2 in Canadian hospital and public health laboratories, and some commercially available real-time RT-PCR assays.", "title_summ": "Immunochromatographic test for the detection of SARS-CoV-2 in salivaExtended Storage of SARS-CoV2 Nasopharyngeal Swabs Does Not Negatively Impact Results of Molecular-Based TestingClinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital settingAd hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samplesSelecting a SARS-CoV-2/COVID molecular testing method for your laboratoryThe importance of cycle threshold values in interpreting molecular tests for SARS- CoV-2Field-deployable, rapid diagnostic testing of saliva samples for SARS-CoV-2.Assessment of samples pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in TunisiaAd hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samplesLow Utility of Repeat Real-Time PCR Testing for SARS-CoV-2 in Clinical SpecimensSARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing proceduresDeveloping a Point-of-Care Molecular Test to Detect SARS-CoV-2Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020Validation of an Aptima-format Finnish new variant of Chlamydia trachomatis (FI-nvCT) surveillance assay, 2019Clinical Application of Rapid Diagnostic Test Kit for SARS-CoV-2 Antibodies into the Field of Patient CareComparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19.Real-time PCR-based SARS-CoV-2 detection in Canadian Laboratories.Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients.", "title_abstract_phrases": "Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital settingThe ongoing SARS-CoV-2 pandemic presents a unique challenge for diagnostic laboratories around the world.SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing proceduresHigh-volume, community-wide ascertainment of SARS-CoV-2 prevalence by PCR and antibody testing was successfully performed using a community-led, drive-through model with strong operational support, well-trained testing units, and an effective technical platform.The ID NOW COVID-19 (IDNCOV) assay performed on the ID Now Instrument (Abbott Diagnostics, Scarborough, Inc. Scarborough, ME) is a rapid diagnostic test that can be performed in a point of care setting equivalent to CLIA waived testing.\u2026.Immunochromatographic test for the detection of SARS-CoV-2 in salivaWe evaluated the rapid immunochromatographic test for SARS-CoV-2 antigen detection using 16 saliva specimens collected from 6 COVID-19 hospitalized patients, and detected N-antigen in 4 of 7 RT-PCR positive specimens.Selecting a SARS-CoV-2/COVID molecular testing method for your laboratoryIn early March 2020 it became apparent that clinical laboratories would need to quickly develop strategies for SARS-CoV-2/COVID-19 testing.Automation of workflows in molecular diagnostics is instrumental for coping with the large number of tests ordered by clinicians, as well as providing fast-tracked rapid testing for urgent cases."}